These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Serum insulin-like growth factor-I and pro-collagen type III N-terminal peptide in adolescent elite athletes: implications for the detection of growth hormone abuse in sport. Guha N; Erotokritou-Mulligan I; Burford C; Strobridge G; Brigg J; Drake T; Bassett EE; Cowan D; Bartlett C; Sönksen PH; Holt RI J Clin Endocrinol Metab; 2010 Jun; 95(6):2969-76. PubMed ID: 20410221 [TBL] [Abstract][Full Text] [Related]
23. Detection of doping with recombinant human growth hormone. He C; Wu M Bioanalysis; 2009 Aug; 1(5):953-65. PubMed ID: 21083065 [TBL] [Abstract][Full Text] [Related]
31. The development of decision limits for the implementation of the GH-2000 detection methodology using current commercial insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays. Erotokritou-Mulligan I; Guha N; Stow M; Bassett EE; Bartlett C; Cowan DA; Sönksen PH; Holt RI Growth Horm IGF Res; 2012 Apr; 22(2):53-8. PubMed ID: 22305721 [TBL] [Abstract][Full Text] [Related]
32. Biomarker detection of rhGH doping: an excretion study. Jing J; Zhou X; He C; Zhang L; Yang S; Xu Y; Xie M; Yan Y; Su H; Wu M Drug Test Anal; 2012 Oct; 4(10):739-44. PubMed ID: 23074170 [TBL] [Abstract][Full Text] [Related]
33. The International Olympic Committee (IOC) and GH-2000. Sönksen P Growth Horm IGF Res; 2009 Aug; 19(4):341-5. PubMed ID: 19473864 [TBL] [Abstract][Full Text] [Related]
34. OMICS-strategies and methods in the fight against doping. Reichel C Forensic Sci Int; 2011 Dec; 213(1-3):20-34. PubMed ID: 21862249 [TBL] [Abstract][Full Text] [Related]
35. Growth hormone and the adolescent athlete: What are the data for its safety and efficacy as an ergogenic agent? Rogol AD Growth Horm IGF Res; 2009 Aug; 19(4):294-9. PubMed ID: 19487146 [TBL] [Abstract][Full Text] [Related]
36. Technology insight: detecting growth hormone abuse in athletes. Bidlingmaier M; Strasburger CJ Nat Clin Pract Endocrinol Metab; 2007 Nov; 3(11):769-77. PubMed ID: 17955018 [TBL] [Abstract][Full Text] [Related]
37. The effects of a freeze-thaw cycle and pre-analytical storage temperature on the stability of insulin-like growth factor-I and pro-collagen type III N-terminal propeptide concentrations: Implications for the detection of growth hormone misuse in athletes. Guha N; Erotokritou-Mulligan I; Bartlett C; Cowan DA; Bassett EE; Stow M; Sönksen PH; Holt RI Drug Test Anal; 2012 Jun; 4(6):455-9. PubMed ID: 22511534 [TBL] [Abstract][Full Text] [Related]
39. Doping control analysis of selected peptide hormones using LC-MS(/MS). Thevis M; Thomas A; Schänzer W Forensic Sci Int; 2011 Dec; 213(1-3):35-41. PubMed ID: 21752560 [TBL] [Abstract][Full Text] [Related]
40. New detection methods of growth hormone and growth factors. Bidlingmaier M Endocr Dev; 2012; 23():52-9. PubMed ID: 23182820 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]